SEC Form 4 · accession 0001236368-18-000002
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walter Gilbert Ph.D.
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2018 | M | 28,811 | $24.39 | A | 56,054 | D | |
| Common Stock | Jun 5, 2018 | S | 28,811 | $39.6816 | D | 27,243 | D | |
| Common Stock | Jun 6, 2018 | M | 1,189 | $24.39 | A | 28,432 | D | |
| Common Stock | Jun 6, 2018 | S | 1,189 | $39.80 | D | 27,243 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $24.39 | Jun 5, 2018 | M | 28,811 | D | Jul 1, 2009 | Nov 13, 2018 | Common Stock | 28,811 | 1,189 | D |
| Non-Qualified Stock Option (right to buy) | $24.39 | Jun 6, 2018 | M | 1,189 | D | Jul 1, 2009 | Nov 13, 2018 | Common Stock | 1,189 | 0 | D |